RUBIUS Trademark

Trademark Overview


On Wednesday, October 11, 2017, a trademark application was filed for RUBIUS with the United States Patent and Trademark Office. The USPTO has given the RUBIUS trademark a serial number of 87641893. The federal status of this trademark filing is REGISTERED as of Tuesday, March 17, 2020. This trademark is owned by Rubius Therapeutics, Inc.. The RUBIUS trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary disease...
rubius

General Information


Serial Number87641893
Word MarkRUBIUS
Filing DateWednesday, October 11, 2017
Status700 - REGISTERED
Status DateTuesday, March 17, 2020
Registration Number6014060
Registration DateTuesday, March 17, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 12, 2018

Trademark Statements


Goods and ServicesCells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders; pharmaceutical preparations of cells for medical or clinical use for the treatment of a variety of human and animal diseases and conditions, namely, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, metabolic diseases and disorders, genetic diseases and disorders, infectious diseases and disorders, cardiovascular diseases and disorders, and other diseases and disorders, namely, neurological diseases and disorders, hematological diseases and disorders, dermatological diseases and disorders, ophthalmological diseases and disorders, gastrointestinal diseases and disorders, genitourinary diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, connective tissues diseases and disorders, and enzyme deficiency diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 30, 2018
Primary Code005
First Use Anywhere DateTuesday, October 15, 2019
First Use In Commerce DateTuesday, October 15, 2019

Trademark Owner History


Party NameRubius Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRubius Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameRubius Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Tuesday, March 17, 2020REGISTERED-PRINCIPAL REGISTER
Wednesday, February 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 12, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 11, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 11, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, February 7, 2020USE AMENDMENT FILED
Tuesday, February 11, 2020EXTENSION 3 GRANTED
Friday, February 7, 2020EXTENSION 3 FILED
Friday, February 7, 2020TEAS EXTENSION RECEIVED
Friday, February 7, 2020TEAS STATEMENT OF USE RECEIVED
Wednesday, August 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2019EXTENSION 2 GRANTED
Wednesday, August 7, 2019EXTENSION 2 FILED
Tuesday, August 13, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 7, 2019TEAS EXTENSION RECEIVED
Wednesday, February 6, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, February 6, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, February 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 31, 2019EXTENSION 1 GRANTED
Thursday, January 31, 2019EXTENSION 1 FILED
Thursday, January 31, 2019TEAS EXTENSION RECEIVED
Tuesday, August 7, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 18, 2018CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Friday, June 15, 2018ASSIGNED TO PETITION STAFF
Tuesday, June 12, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 12, 2018PUBLISHED FOR OPPOSITION
Wednesday, May 23, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 22, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, May 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 2, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 2, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 30, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 27, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 27, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, January 28, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, January 28, 2018NON-FINAL ACTION E-MAILED
Sunday, January 28, 2018NON-FINAL ACTION WRITTEN
Saturday, January 20, 2018ASSIGNED TO EXAMINER
Thursday, October 19, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM